Colon Cancer Prognosis Better information sooner for better decisions
www.ipgdx.com
Colorectal cancer, cancer, also called colon cancer or large bowel cancer, cancer, includes cancerous growths in the colon, rectum and appendix.
Colon cancer is cancer of the large intestine (colon), the lower part of your digestive system.
The symptoms of colorectal cancer depend on the location of tumor in bowel and whether it has spread to elsewhere in the body (metastasis).
There are five five colon cancer stages (0-4).Stage 0 Colon Colon Cancer is the earliest form of cancer where it is in its original place.In stage 1,cancer has extended beyond the innermost layer of the colon into the middle layers of the colon.Colon cancer is considered stage 2 after it moves beyond the middle layers of the colon.If colon cancer is found in at least three lymph nodes, it has reached stage 3.Stage 4 is the most advanced colon cancer stage where the cancer has spread to nearby lymph nodes and other parts of the body.
Most cases of colon cancer begin as small, noncancerous (benign) clumps of cells called adenomatous polyps(adenomatous polyposis).
Adenomatous polyposis syndromes tend to run in families. Such cases are referred to as familial adenomatous polyposis (FAP)
Another group of colon cancer syndromes, termed hereditary nonpolyposis colorectal cancer (HNPCC) syndromes, also run in families. In these syndromes, colon cancer develops without the precursor polyps.
Polyps may be small and due to this reason, doctors recommend regular screening tests to help prevent colon cancer by identifying polyps before they become colon cancer.
A prognosis gives an idea of the likely course and outcome of a disease - that is, the chance that a patient will recover or have a recurrence (return of the cancer).
Colon cancer prognosis is based on several factors, such as the type and location of the cancer and the stage of the disease.Other factors that may affect a colon cancer prognosis include the patient's age, general health, and response to treatment.
PrognostiCheck® is a proprietary noninvasive measurement that depicts prognosis by illustrating the plasma cell membrane and the exchange between the intra and extracellular matrices.
Phase angle determined by PrognostiCheck® detects changes in tissue electrical properties and is a reliable and objective prognostic indicator in several chronic conditions.
People facing colon cancer are naturally concerned about what the future holds.
Understanding colon cancer and what to expect can help patients and their loved ones:
PrognostiCheck
R
For more information or inquiries regarding direct investments, collaborative product development and partnerships please contact below.
By IPGDx, LLC www.ipgdx.com
[email protected] [email protected] 
